PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”

Poly (ADP-ribose) polymerase (PARP) inhibitors are a novel class of therapeutic agents that target tumors with deficiencies in the homologous recombination DNA repair pathway. Genomic instability characterizes high-grade serous ovarian cancer (HGSOC), with one half of all tumors displaying defects i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagnostics (Basel)
Asıl Yazarlar: Boussios, Stergios, Karathanasi, Afroditi, Cooke, Deirdre, Neille, Cherie, Sadauskaite, Agne, Moschetta, Michele, Zakynthinakis-Kyriakou, Nikolaos, Pavlidis, Nicholas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627688/
https://ncbi.nlm.nih.gov/pubmed/31109041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics9020055
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller